CAPTRUST Financial Advisors’s Gossamer Bio GOSS Stock Holding History

CAPTRUST Financial Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5K	Buy	1,022 +303	+42%	+$6.77K	﹤0.01%	3227
2026 Q1	$18.9K	Buy	+719	New	+$90.4K	﹤0.01%	2967
2022 Q3	–	Sell	-5	Closed	-$3K	–	2877
2022 Q2	$3K	Hold	5	–	–	﹤0.01%	4296
2022 Q1	$3K	Buy	5 +2	+67%	+$1.54K	﹤0.01%	4350
2021 Q4	$2K	Hold	3	–	–	﹤0.01%	4410
2021 Q3	$3K	Hold	3	–	–	﹤0.01%	4126
2021 Q2	$2K	Hold	3	–	–	﹤0.01%	4172
2021 Q1	$2K	Buy	+3	New	+$2.42K	﹤0.01%	4042

Other funds holding GOSS

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

DIG

DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

CAPTRUST Financial Advisors's GOSS Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Gossamer Bio (GOSS) stake by 42% in Q2 2026, buying an estimated $6.77K and bringing the position to 1,022 shares worth $13.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3227.

CAPTRUST Financial Advisors first reported a position in GOSS in Q1 2021 and has held it in 8 quarters since. The position peaked at $18.9K in Q1 2026. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

CAPTRUST Financial Advisors held 1,022 shares of Gossamer Bio worth $13.5K as of Q2 2026.
CAPTRUST Financial Advisors bought 303 Gossamer Bio shares in Q2 2026, an estimated $6.77K.
Gossamer Bio made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3227 holding.
CAPTRUST Financial Advisors first reported a position in Gossamer Bio in Q1 2021 and has held it in 8 quarters since.
CAPTRUST Financial Advisors's Gossamer Bio position peaked at $18.9K in Q1 2026.
166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.